Home > Products > CD89 & malaria antigen > Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Triple Body)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Triple Body)  (TRIB-134)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD89 antibody are both extended with the scFv fragment from an anti-malaria antigen antibody. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Specifications

Targets
CD89 & malaria antigen
Type
Triple Body
Species Reactivity
Human
Target 1
CD89
Host Animal 1
Mouse
Target 2
malaria antigen
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Malaria

Targets

Target 1
CD89
Gene ID
UniProt ID
Alternative Names
FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor
Target 2
malaria antigen
Alternative Names
malaria antigen; parasitic protozoans

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Triple Body) (TRIB-134). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD89 & malaria antigen"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: